CVS Health (NYSE:CVS) Raised to Buy at TD Cowen

TD Cowen upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a buy rating in a report published on Friday morning, MarketBeat Ratings reports. They currently have $85.00 price objective on the pharmacy operator’s stock, up from their previous price objective of $59.00. CVS has been the subject of a […]

Leave a Reply

Your email address will not be published.

Previous post Barclays Trims Devon Energy (NYSE:DVN) Target Price to $46.00
Next post McLaren W1: A New Chapter in Supercar Excellence